Table 3 CVA, CVI, CVG, RCV, and II of kidney injury markers within 24 h at 95 % confidence interval
Items | Group | CVA%(95%CI) | CVI %(95%CI) | CVG%(95%CI) | RCV | II |
|---|---|---|---|---|---|---|
s-Crea | All | 2.72 (2.53-2.93) | 7.41 (6.67-8.33) | 24.82 (19.83-33.17) | 21.88 | 0.3 |
Male | 6.91 (6.02-8.11) | 7.93 (5.91-12.07) | ||||
Female | 7.84 (6.73-9.40) | 14.05 (10.18-22.63) | ||||
s-β2MG | All | 2.52(2.34-2.72) | 10.27(9.22-11.60) | 17.41(13.86-23.40) | 29.31 | 0.59 |
Male | 9.99 (8.63-11.86) | 16.22 (11.98-25.11) | ||||
Female | 10.62 (9.10-12.74) | 13.07 (9.47-21.05) | ||||
s-CYSC | All | 2.91 (2.71-3.13) | 4.70 (4.23-5.29) | 14.07 (11.25-18.81) | 15.32 | 0.33 |
Male | 3.07 (2.68-3.61) | 9.65 (7.18-14.68) | ||||
Female | 5.31 (4.54-6.38) | 9.06 (6.57-14.60) | ||||
s-NGAL | All | 2.65 (2.47-2.86) | 11.64 (10.44-13.16) | 22.20 (17.74-29.68) | 33.09 | 0.52 |
Male | 12.09 (10.44-14.35) | 21.33 (15.88-32.46) | ||||
Female | 10.77 (9.21-12.96) | 19.67 (14.26-31.69) | ||||
u-Crea | All | 3.41(3.18-3.68) | 47.40(42.64-53.38) | 37.58(30.03-50.23) | 131.73 | 1.26 |
Male | 45.23 (39.30-53.27) | 29.96 (22.31-45.59) | ||||
Female | 50.50 (43.30-60.59) | 46.45 (33.67-74.83) | ||||
u-β2MG | All | 29.41(27.34-31.82) | 53.00 (47.46-60.03) | 32.17 (25.62-43.24) | 168.01 | 1.65 |
Male | 52.02 (44.57-62.52) | 25.68 (18.97-39.74) | ||||
Female | 53.31 (45.75-63.87) | 34.01 (24.65-54.79) | ||||
u-CYSC | All | 44.42(41.40-47.93) | 59.85 (53.86-67.34) | 57.80 (46.19-77.26) | 206.59 | 1.04 |
Male | 44.25 (38.54-51.96) | 52.13 (38.82-79.34) | ||||
Female | 64.09 (54.90-77.02) | 52.94 (38.38-85.29) | ||||
u-NGAL | All | 8.33 (7.73-9.02) | 61.82 (55.22-70.22) | 24.46 (19.54-32.69) | 172.90 | 2.53 |
Male | 64.37 (55.51-76.61) | 21.72 (16.18-33.05) | ||||
Female | 58.93 (49.95-71.88) | 22.56 (16.36-36.35) |